Cancer cell resistance to CD8+ T cell killing can be mediated through a variety of intrinsic mechanisms, including upregulation of immune checkpoints, granzyme inhibitors, or antiapoptotic factors, and downregulation of MHC class I molecules (31–35). Here, CD8A is linked to cancer.